跳至主要内容
临床试验/NCT05737602
NCT05737602进行中(未招募)不适用

Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年7月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
40
试验地点
2
主要终点
3RP-VHL Feasibility: Proportion of Participants Completing the 3RP-VHL Program

研究概览

简要总结

The Relaxation Response Resiliency Program (3RP) has shown efficacy in improving coping and resilience across diverse populations; however, little is known about how it helps individuals manage the challenges of living with a chronic illness. This study proposes to pilot test an adapted version of the 3RP among patients living with VHL.

详细描述

The 3RP has not been carried out with VHL patients. As such, the investigators are looking to see if an adapted program, tailored to the needs of patients with VHL, is feasible, acceptable, and helpful in improving coping among individuals living with VHL.

This study is a two phase trial. Phase I is descriptive. It is comprised of conducting interviews with patients and caregivers to understand the challenges of living with VHL and patient's programatic needs. This information will be used to tailor the program for patients living with VHL. Phase II is a single-arm feasibility trial that will examine if the adapted program is feasible, acceptable, and helps promote stress management among VHL patients. To these means, we will test the adapted 3RP (3RP-VHL) in up to 40 patients living with VHL. Participants will complete surveys at baseline and post 3RP-VHL program completion. This record will reflect the trial component (Phase II) only, as feasibility and acceptability outcomes will be collected for this phase.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of VHL

排除标准

  • Is medically, psychiatrically, or otherwise unable to participate (as determined by a physician or study PI).
  • Unwilling or unable to participate in study sessions delivered via Partners Telehealth videoconferencing.
  • Participated in Phase 1 qualitative interview.

研究组 & 干预措施

3RP-VHL

Experimental
  • An adapted version of the 3RP (3RP-VHL) for individuals with VHL. The adapted program incorporates the three prongs of the 3RP: RR elicitation, stress awareness, and adaptive strategies. It will be delivered in weekly sessions over the course of approximately 8 weeks.
  • Complete pre- and post-intervention surveys.

干预措施: 3RP-VHL (Behavioral)

结局指标

主要结局

3RP-VHL Feasibility: Proportion of Participants Completing the 3RP-VHL Program

时间窗: Post-treatment completion (treatment is approximately 2 months)

Among those who initiated the program, this is the proportion of patients who completed the program (defined as completing 6 out of 8 sessions). Participants who complete at least 75% of the treatment sessions (6 out of 8 sessions) will be identified as treatment completers.

3RP-VHL Feasibility: Percent of Identified Eligibles Who Enroll

时间窗: Post-treatment completion (treatment is approximately 2 months)

Percent of identified eligibles who were approached (hence given the opportunity to participate) who enroll (i.e., sign consent and complete baseline).

3RP-VHL Acceptability: Five Questions

时间窗: Post-treatment completion (treatment is approximately 2 months)

Acceptability will be assessed with five questions rated on a 4-point Likert scale (1=not at all to 4=very). More specifically, acceptability will be defined as ≥75% of responses rated at least 3/4 on enjoyableness, convenience, helpfulness, future use, and satisfaction.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Giselle K. Perez Lougee

Principal Investigator

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验